Colgate-Palmolive Company Company Profile (NYSE:CL)

Colgate-Palmolive Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "CL."

Colgate-Palmolive Company announced a quarterly dividend on Thursday, June 8th. Stockholders of record on Tuesday, July 18th will be paid a dividend of $0.40 per share on Tuesday, August 15th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.20%. The ex-dividend date is Friday, July 14th. View Colgate-Palmolive Company's Dividend History.

Colgate-Palmolive Company (NYSE:CL) posted its quarterly earnings results on Friday, July, 21st. The company reported $0.72 EPS for the quarter, meeting the consensus estimate of $0.72. The firm had revenue of $3.83 billion for the quarter, compared to analysts' expectations of $3.89 billion. Colgate-Palmolive Company had a net margin of 15.83% and a return on equity of 3,121.95%. The company's revenue was down .5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.70 earnings per share. View Colgate-Palmolive Company's Earnings History.

Colgate-Palmolive Company is scheduled to release their next quarterly earnings announcement on Friday, October, 27th 2017. View Earnings Estimates for Colgate-Palmolive Company.

13 equities research analysts have issued twelve-month target prices for Colgate-Palmolive Company's shares. Their forecasts range from $68.00 to $80.00. On average, they expect Colgate-Palmolive Company's share price to reach $74.91 in the next twelve months. View Analyst Ratings for Colgate-Palmolive Company.

Here are some recent quotes from research analysts about Colgate-Palmolive Company stock:

• 1. According to Zacks Investment Research, "Colgate has underperformed the broader industry in the last three months. While the company’s bottom-line trends remain impressive, its top line continues to suffer. The company’s sales fell short of expectations for the fifth straight quarter in the recently reported second-quarter 2017 due to the persistence of softness in North America and challenges in Asia-Pacific. Further, the company lagged sales estimates in 16 out of the trailing 17 quarters. Going forward, Colgate anticipates the backdrop to remain challenging due to uncertain global markets and slowing category growth worldwide. This aong with a soft first half 2017, led it to trim GAAP earnings guidance for 2017. Estimates witnessed a downtrend. However, Colgate remains encouraged by the progress on its 2012 Restructuring Program and expects additional opportunities identified under the program to help reach the higher end of its previously stated cost and savings view." (7/27/2017)
• 2. Jefferies Group LLC analysts commented, "Late Tues. (5/16), the NY Post reported that CL Chair/CEO Ian Cook recently told investors he would consider selling the company for $100/share (~19.5x EV/EBITDA). While we have no knowledge of any potential M&A or the specific accuracy of this report, this strikes us as a reasonable price (for both a potential buyer and for CL as sellers). We view JNJ as the most likely acquirer, followed by ULVR and KHC/3G. Valuation remains nearly full, reit. $76 PT, Hold. CL CEO/Chairman Ian Cook reportedly would consider selling for $100/share: Late Tuesday, the NY Post reported the Ian Cook, Colgate’s Chairman and CEO, recently signaled he would be open to selling the company… for $100/share", while at a meeting with institutional investors. The Post further noted recent speculation the CL is being stalked by" Unilever and pointed to activist Nelson Peltz’s stake in P&G as a potential spark for sector consolidation." (5/17/2017)

Colgate-Palmolive Company saw a decrease in short interest during the month of August. As of August 31st, there was short interest totalling 4,803,434 shares, a decrease of 36.6% from the August 15th total of 7,575,369 shares. Based on an average daily volume of 2,703,602 shares, the short-interest ratio is presently 1.8 days. Approximately 0.5% of the shares of the stock are sold short.

Some companies that are related to Colgate-Palmolive Company include Unilever plc (ULVR), Estee Lauder Companies, Inc. (The) (EL), Herbalife LTD. (HLF), Energizer Holdings (EPC), Nu Skin Enterprises (NUS), Matthews International Corporation (MATW), PZ Cussons plc (PZC), USANA Health Sciences (USNA), Avon Products (AVP), Revlon (REV), Nautilus Group, Inc. (The) (NLS), KP Tissue (KPT), Swallowfield plc (SWL), Blackmores Limited (BKL), DS Healthcare Group (DSKX), L'Oreal SA (OR) and Litebulb Group Ltd (LBB).

Colgate-Palmolive Company's management team includes the folowing people:

• Ian M. Cook, Chairman of the Board, President, Chief Executive Officer
• Daniel B. Marsili, Chief Human Resource Officer
• John J. Huston, Senior Vice President - Chief of Staff
• Patricia Verduin Ph.D., Chief Technology Officer
• Mukul V. Deoras, Chief Marketing Officer
• Victoria L. Dolan, Chief Transformation Officer, Corporate Controller
• Delia H. Thompson, Chief Investor Relations Officer
• Makarand Karnataki, Company Secretary and Compliance Officer
• Jennifer M. Daniels, Chief Legal Officer and Secretary
• Charles A. Bancroft, Independent Director

Colgate-Palmolive Company's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (7.71%), State Street Corp (6.67%), BlackRock Inc. (5.77%), FMR LLC (3.18%), Bank of New York Mellon Corp (2.05%) and Northern Trust Corp (1.20%). Company insiders that own Colgate-Palmolive Company stock include Daniel B Marsili, Delano E Lewis, Delia H Thompson, Dennis J Hickey, Ellen M Hancock, Fabian T Garcia, Franck J Moison, Ian M Cook, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Mukul Deoras, Noel R Wallace, Patricia Verduin, Richard J Kogan, Stephen I Sadove and Victoria L Dolan. View Institutional Ownership Trends for Colgate-Palmolive Company.

Colgate-Palmolive Company's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Sustainable Growth Advisers LP, State Street Corp, Capital World Investors, Ameriprise Financial Inc., Bank of New York Mellon Corp, BlackRock Inc. and Aviva PLC. Company insiders that have sold Colgate-Palmolive Company stock in the last year include Daniel B Marsili, Dennis J Hickey, Ellen M Hancock, Franck J Moison, Jennifer Daniels, John J Huston, John T Cahill, Justin Skala, Patricia Verduin, Richard J Kogan and Stephen I Sadove. View Insider Buying and Selling for Colgate-Palmolive Company.

Colgate-Palmolive Company's stock was acquired by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Vanguard Group Inc., Arrowstreet Capital Limited Partnership, Parametric Portfolio Associates LLC, Fiera Capital Corp, HAP Trading LLC, Principal Financial Group Inc. and MARSHALL WACE ASIA Ltd. View Insider Buying and Selling for Colgate-Palmolive Company.

Shares of Colgate-Palmolive Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Colgate-Palmolive Company stock can currently be purchased for approximately $72.81.